These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 8586834)

  • 1. Cyclosporin-induced renal vasoconstriction is augmented by frusemide and by angiotensin II in humans.
    Sturrock ND; Lang CC; Coutie WJ; Struthers AD
    J Hypertens; 1995 Sep; 13(9):987-91. PubMed ID: 8586834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II as a risk factor for cyclosporin nephrotoxicity in patients with psoriasis.
    Edwards BD; Chalmers RJ; O'Driscoll JB; Mitchell DM; Smith RJ; Lawson RS; Testa HJ; Ballardie FW
    Clin Nephrol; 1994 Jun; 41(6):350-6. PubMed ID: 8076438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal vascular effects of frusemide in the rat: influence of salt loading and the role of angiotensin II.
    Dobrowolski L; Badzyńska B; Grzelec-Mojzesowicz M; Sadowski J
    Exp Physiol; 2001 Sep; 86(5):611-6. PubMed ID: 11571489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute renal effects of AT1-receptor blockade after exogenous angiotensin II infusion in healthy subjects.
    Schmitt F; Martinez F; Brillet G; Nguyen-Khoa T; Brouard R; Sissmann J; Lacour B; Grunfeld JP
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):314-21. PubMed ID: 9475275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indomethacin and cyclosporin together produce marked renal vasoconstriction in humans.
    Sturrock ND; Lang CC; Struthers AD
    J Hypertens; 1994 Aug; 12(8):919-24. PubMed ID: 7814851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
    Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC
    Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal effects of angiotensin I-receptor blockade and angiotensin convertase inhibition in man.
    Schmitt F; Natov S; Martinez F; Lacour B; Hannedouche TP
    Clin Sci (Lond); 1996 Mar; 90(3):205-13. PubMed ID: 8777826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sodium depletion on the role of AT1- and alpha-adrenergic receptors in the regulation of forearm vascular tone in humans.
    Baan J; Chang PC; Vermeij P; Pfaffendorf M; van Zwieten PA
    J Hypertens; 1999 Feb; 17(2):229-35. PubMed ID: 10067792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial changes in blood pressure, renal function, endothelin and lipoprotein (a) during the first 9 days of cyclosporin therapy in males.
    Sturrock ND; Lang CC; MacFarlane LJ; Dockrell ME; Ryan M; Webb DJ; Struthers AD
    J Hypertens; 1995 Jun; 13(6):667-73. PubMed ID: 7594425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of the renin-angiotensin-aldosterone system to upright tilting and to intravenous frusemide: effect of prior metoprolol and propranolol.
    Sonkodi S; Agabiti-Rosei E; Fraser R; Leckie BJ; Morton JJ; Cumming AM; Sood VP; Robertson JI
    Br J Clin Pharmacol; 1982 Mar; 13(3):341-50. PubMed ID: 6120716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of gender on the renal response to angiotensin II.
    Miller JA; Anacta LA; Cattran DC
    Kidney Int; 1999 Jan; 55(1):278-85. PubMed ID: 9893137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the acute renal and peripheral vascular responses to frusemide and bumetanide at low and high dose.
    Passmore AP; Whitehead EM; Johnston GD
    Br J Clin Pharmacol; 1989 Mar; 27(3):305-12. PubMed ID: 2655681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of captopril on renal haemodynamics and the renin-angiotensin-aldosterone and osmoregulatory systems in essential hypertension.
    Thomsen OO; Danielsen H; Sørensen SS; Pedersen EB
    Eur J Clin Pharmacol; 1986; 30(1):1-6. PubMed ID: 3519238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The renin angiotensin aldosterone system and frusemide response in congestive heart failure.
    Reed S; Greene P; Ryan T; Cerimele B; Schwertschlag U; Weinberger M; Voelker J
    Br J Clin Pharmacol; 1995 Jan; 39(1):51-7. PubMed ID: 7756099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The renin-angiotensin system during pregnancy in chronically instrumented, conscious rats.
    Conrad KP; Morganelli PM; Brinck-Johnsen T; Colpoys MC
    Am J Obstet Gynecol; 1989 Oct; 161(4):1065-72. PubMed ID: 2552805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the converting enzyme inhibitor enalapril in renovascular hypertension. Effect on blood pressure, renal function, and the renin-angiotensin-aldosterone system.
    Reams GP; Bauer JH; Gaddy P
    Hypertension; 1986 Apr; 8(4):290-7. PubMed ID: 3007351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of vasoconstriction by frusemide in the rat.
    Gerkens JF; Smith AJ
    Br J Pharmacol; 1984 Oct; 83(2):363-71. PubMed ID: 6487901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of atrial natriuretic factor on blood pressure and the renin-angiotensin-aldosterone system.
    Atlas SA; Volpe M; Sosa RE; Laragh JH; Camargo MJ; Maack T
    Fed Proc; 1986 Jun; 45(7):2115-21. PubMed ID: 2940120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.